Literature DB >> 6196354

The regulation of glucose transport by cAMP stimulators via three different mechanisms in rat and human adipocytes.

A Kashiwagi, T P Huecksteadt, J E Foley.   

Abstract

The regulation of glucose transport by a beta-adrenergic agonist and other cAMP stimulators was assessed by kinetic analyses of 3-O-methylglucose (MG) transport in rat and human adipocytes and in isolated rat plasma membrane vesicles. Basal MG transport was biphasically affected by L-isoproterenol in rat adipocytes: lower concentrations (10-25 nM) of L-isoproterenol stimulated the basal rate by increasing the Vmax, but higher concentrations (0.5-2 microM) of L-isoproterenol inhibited the basal rate. On the other hand, the maximum insulin-stimulated MG transport rate was not affected by 25 nM L-isoproterenol, but was suppressed by 2 microM L-isoproterenol in rat adipocytes. In the presence of adenosine deaminase plus L-isoproterenol (25 nM and 2 microM), dibutyryl cyclic AMP (Bt2cAMP), 3-isobutyl-1-methylxanthine, or forskolin, both basal and the maximum rates of MG transport were suppressed in rat adipocytes. However, from kinetic experiments, both L-isoproterenol plus adenosine deaminase and Bt2cAMP decreased the Vmax. On the other hand, isobutymethylxanthine and forskolin decreased the Vmax as well as increased the K8. MG transport in plasma membrane vesicles was directly inhibited by either forskolin or isobutylmethylxanthine. In contrast, both 25 nM and 2 microM L-isoproterenol with or without adenosine deaminase, Bt2cAMP, or cAMP had no effect on MG transport in rat plasma membrane vesicles. In human adipocytes, L-isoproterenol always stimulated basal MG transport and did not suppress the maximum rate of MG transport, even though cAMP production was maximally stimulated by L-isoproterenol. Both adenosine deaminase plus L-isoproterenol and Bt2cAMP did not suppress the basal rate, but did show a modest suppression (40%) of the maximum insulin effect on MG transport in human adipocytes. However, both isobutylmethylxanthine and forskolin remarkably suppressed (85%) both the basal and the maximum rate of MG transport by both increasing the K8 and decreasing the Vmax. These results indicate MG transport in both rat and human adipocytes is regulated by 3 different mechanisms: (I) L-isoproterenol, a beta-adrenergic agonist, stimulates basal MG transport by increasing the Vmax, (II) cAMP mediates a decrease in MG transport by decreasing the Vmax, and (III) both forskolin and isobutylmethylxanthine also decrease MG transport by directly inhibiting the binding of MG molecules to transporters, resulting in a decrease in the Vmax and an increase in the K8.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6196354

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Role of glucose transporters in the cellular insulin resistance of type II non-insulin-dependent diabetes mellitus.

Authors:  W T Garvey; T P Huecksteadt; S Matthaei; J M Olefsky
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

2.  Prostaglandin E2 differentiates between two forms of glucose transport inhibition by lipolytic agents.

Authors:  H J Steinfelder; S Schramm; H G Joost
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-07       Impact factor: 3.000

3.  Inhibition by forskolin of insulin-stimulated glucose transport in L6 muscle cells.

Authors:  A Klip; T Ramlal; A G Douen; P J Bilan; K L Skorecki
Journal:  Biochem J       Date:  1988-11-01       Impact factor: 3.857

4.  Isoproterenol inhibits cyclic AMP-mediated but not insulin-mediated translocation of the GLUT4 glucose transporter isoform.

Authors:  S L Macaulay; A S Kelada; J Proietto
Journal:  Mol Cell Biochem       Date:  1994-12-07       Impact factor: 3.396

5.  Isoproterenol stimulates phosphorylation of the insulin-regulatable glucose transporter in rat adipocytes.

Authors:  D E James; J Hiken; J C Lawrence
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

6.  Glyceroneogenesis is the dominant pathway for triglyceride glycerol synthesis in vivo in the rat.

Authors:  Colleen K Nye; Richard W Hanson; Satish C Kalhan
Journal:  J Biol Chem       Date:  2008-07-28       Impact factor: 5.157

7.  Sustained βAR Stimulation Mediates Cardiac Insulin Resistance in a PKA-Dependent Manner.

Authors:  Supachoke Mangmool; Tananat Denkaew; Sarawuth Phosri; Darawan Pinthong; Warisara Parichatikanond; Tsukasa Shimauchi; Motohiro Nishida
Journal:  Mol Endocrinol       Date:  2015-12-11

8.  N6-(Phenylisopropyl)adenosine prevents glucagon both blocking insulin's activation of the plasma-membrane cyclic AMP phosphodiesterase and uncoupling hormonal stimulation of adenylate cyclase activity in hepatocytes.

Authors:  A V Wallace; C M Heyworth; M D Houslay
Journal:  Biochem J       Date:  1984-08-15       Impact factor: 3.857

9.  Cyclic AMP impairs the rapid effect of insulin to enhance cell-surface insulin-binding capacity in rat adipocytes.

Authors:  J W Eriksson; P Lönnroth; U Smith
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

10.  Phosphorylation state of the GLUT4 isoform of the glucose transporter in subfractions of the rat adipose cell: effects of insulin, adenosine, and isoproterenol.

Authors:  H Nishimura; J Saltis; A D Habberfield; N B Garty; A S Greenberg; S W Cushman; C Londos; I A Simpson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.